Literature DB >> 26457460

Does Improving Exercise Capacity and Daily Activity Represent the Holistic Perspective of a New COPD Approach?

Fabiano Di Marco1, Pierachille Santus2, Giovanni Sotgiu3, Francesco Blasi4, Stefano Centanni1.   

Abstract

In COPD patients a reduced daily activity has been well documented, resulting from both respiratory and non-respiratory manifestations of the disease. An evaluation by multisensory armband has confirmed that daily physical activity is mainly associated with dynamic hyperinflation, regardless of COPD severity. This aspect is crucial, since exercise capacity is closely correlated to life expectancy. Notwithstanding the causal key role of lung impairment in the patient's symptoms, some authors have suggested that other factors, such as systemic inflammation and co-morbidities, have an important role, particularly as mortality risk factors. Many studies suggest the efficacy of bronchodilators and rehabilitation in improving exercise capacity, and, speaking in terms of daily life, in increasing the number of days in which patients are able to perform their usual activities. On this evidence, the first aim in the management of COPD should be to improve exercise capacity and daily activity since these outcomes have direct effects on patients' quality of life, co-morbidities (heart and metabolic diseases), and prognosis. Thus, improving physical activity represents a modern approach aimed at dealing with both pulmonary and systemic manifestations of the disease. It is however worth of notice to remember that in patients affected by COPD the relationship between the improvement of "potential" exercise capacity and daily physical activity has been found to be only moderate to weak. Obtaining a significant behavior modification with regard to daily physical activity, together with the optimization of therapy thus represents currently the true challenge.

Entities:  

Keywords:  airflow limitation; bronchodilation; co-morbidities; dyspnea; inflammation; rehabilitation

Mesh:

Year:  2015        PMID: 26457460     DOI: 10.3109/15412555.2015.1008694

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  5 in total

1.  Conceptual validation of an innovative remote pulmonary rehabilitation solution for Chronic Obstructive Pulmonary Disease.

Authors:  Andrea Méndez; Patricio Labra; Juan Pablo Guerrero; Carlos Nieto; Bárbara Martínez; Gonzalo Hidalgo; Iván Rodríguez-Núñez
Journal:  Can J Respir Ther       Date:  2021-08-18

2.  Depression symptoms reduce physical activity in COPD patients: a prospective multicenter study.

Authors:  Iván Dueñas-Espín; Heleen Demeyer; Elena Gimeno-Santos; Michael I Polkey; Nicholas S Hopkinson; Roberto A Rabinovich; Fabienne Dobbels; Niklas Karlsson; Thierry Troosters; Judith Garcia-Aymerich
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-06-10

Review 3.  Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis.

Authors:  Fabiano Di Marco; Giovanni Sotgiu; Pierachille Santus; Denis E O'Donnell; Kai-Michael Beeh; Simone Dore; Maria Adelaide Roggi; Lisa Giuliani; Francesco Blasi; Stefano Centanni
Journal:  Respir Res       Date:  2018-01-24

4.  Identification of Inflammation-Related Biomarker Lp-PLA2 for Patients With COPD by Comprehensive Analysis.

Authors:  Mingming Deng; Yan Yin; Qin Zhang; Xiaoming Zhou; Gang Hou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

5.  Ultrasound assessment of the rectus femoris in patients with chronic obstructive pulmonary disease predicts poor exercise tolerance: an exploratory study.

Authors:  Mingming Deng; Chaonan Liang; Yan Yin; Jun Shu; Xiaoming Zhou; Qiuyue Wang; Gang Hou; Chen Wang
Journal:  BMC Pulm Med       Date:  2021-09-25       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.